The global ceramide market size reached US$372.9 million ($545.53 million) in 2022.
Looking forward, IMARC Group expects the market to reach US$531.9 million ($778.14 million) by 2028, exhibiting a growth rate of 5.5 per cent during 2023-2028.
QV Ceramides uses the latest technology to help revitalise the skin’s look and feel and is suitable for those with eczema-prone and acne prone skin.
Individuals who suffer from eczema and psoriasis have a significant reduction of ceramides in their skin.
The new range’s formula of triple ceramides, glycerin and niacinamide helps to support the skin’s barrier for a fresh, glowing complexion.
QV Ceramides is owned by Ego Pharmaceuticals, which has paved the way in the development, manufacturing and marketing of innovative skincare products for 70 years.
Available in three new products; QV Ceramides Cleanser, QV Ceramides Lotion, and QV Ceramides Cream, the range provides 24-hour hydration and moisturisation to the skin.
QV Ceramides Brand Manager Clare Vercoe said – “The QV Ceramides range is our latest innovation designed to help support the skin barrier on the face and body, which caters towards a younger demographic of Australians.”
The QV Ceramides range was officially launched at Oxford House, Paddington.
Speaking at the event, reality TV star and brand ambassador Tayla Broad, said – “QV has been my go-to skincare brand because of its gentle formula and unmatched ability to hydrate and moisturise dry skin, which is essential when growing up in Australia.”
Images from the launch event below. Photos by @studiolatessa.
